Firefly Neuroscience shares are trading higher after the company announced a public-private partnership to support the assessment and treatment of active-duty U.S. service members and veterans suffering from Post-Traumatic Stress Disorder and/or Traumatic Brain Injury.

AIFF

<p>Firefly Neuroscience shares are trading higher after the company announced a public-private partnership to support the assessment and treatment of active-duty U.S. service members and veterans suffering from Post-Traumatic Stress Disorder and/or Traumatic Brain Injury.</p>

benzinga_article

VanEck Biotech ETF

Firefly Neuroscience

Invesco Biotechnology & Genome ETF

iShares US Medical Devices

SPDR S&P Health Equip

iShares Biotechnology ETF

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

First Trust NYSE Arca Biotech Index Fd

News